D.E. Shaw & Co’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,967
Closed -$189K 4308
2021
Q4
$189K Buy
20,967
+5,469
+35% +$49.3K ﹤0.01% 3503
2021
Q3
$253K Buy
+15,498
New +$253K ﹤0.01% 3144